When I was first invited to provide my perspective on female leadership in pharma, I was admittedly surprised and wondered if there are special features on male leadership or why the experience of ‘female leadership’ should be seen as different from ‘leadership’ in general.
Leadership, in its essence, should be a universal concept, transcending gender. Additionally, the pharmaceutical industry has seen an increase in female representation in leadership roles since I started my career.
Women hold about 25% of executive committee roles in pharmaceutical companies within the FTSE 350, which is higher than the cross-industry average, and we also have notable female CEOs. Still, the ‘glass ceiling’ effect is prevalent, making it more difficult for women to advance to higher levels of management.
Check out the rest of the feature here
